Author/Authors :
Sanati Hamidreza نويسنده Rajaei Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran. , Shakerian Ghahferokhi Farshad نويسنده Cardiovascular Intervention Research Center, Shaheed Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, , Kiani Reza نويسنده Cardiovascular Intervention Research Center, Shaheed Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, , Firouzi Ata نويسنده Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical and Research Center, Tehran University of Medical Sciences, Tehran, Iran. , Aeinfar Kamran نويسنده Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran , Shahsavari Hossein نويسنده Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran , Zahed Mehr Ali نويسنده Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Abstract :
Background: No-reflow phenomenon is a serious complication of primary Percutaneous
Coronary Intervention (PCI), which may increase the risk of progressive myocardial
damage, profound left ventricular dysfunction, and death.
Objectives: This study aimed to investigate the incidence of no-reflow phenomenon and
its clinical, para-clinical, and angiographic determinants in patients who underwent
primary PCI for ST Elevation Myocardial Infarction (STEMI).
Patients and Methods: This non-randomized prospective cohort study was conducted
on 397 patients in a cardiovascular tertiary care center in Tehran, Iran from April 2012 to
April 2014. The inclusion criteria of the study were presenting with acute STEMI of ? 12
h duration or having admitted between 12 and 24 hours after onset with symptoms and
signs of ongoing ischemia. The participants underwent standard coronary angiography.
No-reflow phenomenon was defined as a Thrombolysis In Myocardial Infarction (TIMI)
flow ? 2 and no presence of spasm, distal embolization, or dissection after completion of
the procedure. The association between no-reflow and its determinants was assessed by
chi-square, student’s t-test, or Mann–Whitney U test. Logistic regression models were
also used for multivariate analysis. P values < 0.05 were considered to be statistically
significant.
Results: The participants’ mean (SD) age was of 59 (12.2) years and female/male ratio
was 83/314. The incidence of no-reflow phenomenon was 63 (15.9%). Besides, the results
of multivariate analysis showed that only thrombus burden, lesion length, time to
reperfusion, and type of occlusion had an adjusted association with this phenomenon.
Conclusions: The study results suggested that no-reflow phenomenon after primary PCI
would be predictable. Thus, preventive measures, such as using distal protective devices
or administration of platelet glycoprotein IIb/IIIa antagonists, are advised to be used in
high-risk patients.